Results 1 to 10 of about 87,432 (237)
Performance Evaluation of AFIAS ST2 and Ichroma ST2 Assays in Comparison with Presage ST2 Assay
Reviews in Cardiovascular Medicine, 2023 Background: Elevated soluble suppression of tumorigenicity 2 (sST2) levels may predict mortality in heart failure (HF) patients. The AFIAS ST2 assay (AFIAS ST2, Boditech Med Inc., Chuncheon, Korea) and ichroma ST2 assay (ichroma ST2, Boditech Med Inc ...
Hanah Kim +6 more
doaj +3 more sources
An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice [PDF]
Brazilian Journal of Medical and Biological Research, 2013 Interleukin (IL)-33, the most recent member of the IL family of cytokines, signals through the ST2 receptor. IL-33/ST2 signaling mediates antigen challenge-induced mechanical hyperalgesia in the joints and cutaneous tissues of immunized ...
D.A.C. Magro +9 more
doaj +5 more sources
ST2/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche [PDF]
Nature CommunicationsAcute myeloid leukemia (AML) patients present with CD8 exhaustion signatures, and pharmacologic inhibition of checkpoints can have therapeutic benefit. The alarmin IL-33 and its receptor STimulation-2 (ST2) promote activation of tissue-regulatory T cells
Hua Jiang +21 more
doaj +2 more sources
The search for novel biomarkers in sepsis-induced cardiomyopathy – A new challenge to overcome [PDF]
Romanian Journal of Pharmaceutical Practice, 2022 Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection and it remains the most frequent cause of death amongst critically ill patients worldwide, despite recent medical advancements.
Cristian Sorin Prepeliuc +7 more
doaj +1 more source
Dynamics of NT-proBNP and ST2 levels as markers of heart failure in patients with endogenous Cushing syndrome (hypercortisolism) [PDF]
Терапевтический архив, 2023 Aim. To evaluate frequency of heart failure syndrome in patients with endogenous hypercortisolism and to establish relationship between effective treatment for hypercortisolism and regression of heart failure with particular emphasis on the observation ...
Raisa S. Kosharnaia +4 more
doaj +1 more source
Российский кардиологический журнал, 2023 Aim. To develop a predictive model of the risk of adverse outcomes within 12 months after myocardial infarction (MI) in patients over 70 years of age with frailty syndrome.Material and methods.
O. Yu. Aidumova +2 more
doaj +1 more source
Наука и инновации в медицине, 2021 Objectives to determine the clinical and instrumental relationships and prognostic value of sST2 in chronic heart failure with reduced and mid-range ejection fraction of ischemic etiology. Material and methods.
Natalya V. Kompanets +2 more
doaj +1 more source
Sex-Specific Thresholds for Cardiac Biomarkers—We Need to Move Forward
Reviews in Cardiovascular Medicine, 2023 Cardiovascular biomarkers play a major diagnostic role for cardiologists. Different biomarkers provide different insights into a variety of cardiovascular conditions and in doing so they improve diagnosis and management.
Ronstan Lobo, Allan S. Jaffe
doaj +1 more source
Journal of Innate Immunity, 2023 The innate cytokine IL-33 is increasingly recognised to possess biological effects on various immune cells. We have previously demonstrated elevated serum level of soluble ST2 in patients with active systemic lupus erythematosus suggesting involvement of
Mo Yin Mok +8 more
doaj +1 more source
ST2 in Stable and Unstable Ischemic Heart Diseases [PDF]
, 2015 Circulating suppression of tumorigenicity 2 (ST2) predicts cardiovascular outcomes and mortality in ischemic heart disease (IHD). ST2 does not correlate with traditional risk indicators as closely as N-terminal pro–brain natriuretic peptide (NT-proBNP ...
DI SOMMA, Salvatore +2 more
core +1 more source